These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23085186)

  • 1. Predicting return of fear following exposure therapy with an implicit measure of attitudes.
    Vasey MW; Harbaugh CN; Buffington AG; Jones CR; Fazio RH
    Behav Res Ther; 2012 Dec; 50(12):767-74. PubMed ID: 23085186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emotional variability and sustained arousal during exposure.
    Culver NC; Stoyanova M; Craske MG
    J Behav Ther Exp Psychiatry; 2012 Jun; 43(2):787-93. PubMed ID: 22123332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms, genes and treatment: Experimental fear conditioning, the serotonin transporter gene, and the outcome of a highly standardized exposure-based fear treatment.
    Wannemueller A; Moser D; Kumsta R; Jöhren HP; Adolph D; Margraf J
    Behav Res Ther; 2018 Aug; 107():117-126. PubMed ID: 29960126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A brief protocol of cognitive modification and gradual exposure for reduction of fear symptoms of public speaking.
    Kozasa EH; Leite JR
    J Behav Ther Exp Psychiatry; 1998 Dec; 29(4):317-26. PubMed ID: 10037228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential predictive power of self report and implicit measures on behavioural and physiological fear responses to spiders.
    Van Bockstaele B; Verschuere B; Koster EH; Tibboel H; De Houwer J; Crombez G
    Int J Psychophysiol; 2011 Feb; 79(2):166-74. PubMed ID: 20951174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fear reactivation prior to exposure therapy: does it facilitate the effects of VR exposure in a randomized clinical sample?
    Shiban Y; Brütting J; Pauli P; Mühlberger A
    J Behav Ther Exp Psychiatry; 2015 Mar; 46():133-40. PubMed ID: 25460259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive valence reduces susceptibility to return of fear and enhances approach behavior.
    Dour HJ; Brown LA; Craske MG
    J Behav Ther Exp Psychiatry; 2016 Mar; 50():277-82. PubMed ID: 26497447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Scarier the Better: Maximizing Exposure Therapy Outcomes for Spider Fear.
    Norberg MM; Newins AR; Jiang Y; Xu J; Forcadell E; Alberich C; Deacon BJ
    Behav Cogn Psychother; 2018 Nov; 46(6):754-760. PubMed ID: 30001760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of repeated exposure to fearful and disgusting stimuli on fear renewal in blood-injection-injury phobia.
    Jessup SC; Tomarken A; Viar-Paxton MA; Olatunji BO
    J Anxiety Disord; 2020 Aug; 74():102272. PubMed ID: 32682277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural responses during extinction learning predict exposure therapy outcome in phobia: results from a randomized-controlled trial.
    Lange I; Goossens L; Michielse S; Bakker J; Vervliet B; Marcelis M; Wichers M; van Os J; van Amelsvoort T; Schruers K
    Neuropsychopharmacology; 2020 Feb; 45(3):534-541. PubMed ID: 31352467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attentional focus during exposure in spider phobia: The effect of valence and schematicity of a partial distractor.
    Dethier V; Philippot P
    Behav Res Ther; 2017 Jun; 93():104-115. PubMed ID: 28395157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treating specific childhood phobia in a single session? A systematic review of the literature].
    Fond G; Franc N
    Encephale; 2013 Apr; 39(2):109-14. PubMed ID: 23095586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
    Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
    Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure treatment in multiple contexts attenuates return of fear via renewal in high spider fearful individuals.
    Bandarian-Balooch S; Neumann DL; Boschen MJ
    J Behav Ther Exp Psychiatry; 2015 Jun; 47():138-44. PubMed ID: 25601294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial.
    van der Flier FE; Kwee CMB; Cath DC; Batelaan NM; Groenink L; Duits P; van der Veen DC; van Balkom AJLM; Baas JMP
    BMC Psychiatry; 2019 Feb; 19(1):69. PubMed ID: 30760241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalization of Extinguished Fear to Untreated Fear Stimuli after Exposure.
    Preusser F; Margraf J; Zlomuzica A
    Neuropsychopharmacology; 2017 Dec; 42(13):2545-2552. PubMed ID: 28589965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-based mediation of non-conscious reduction of phobic avoidance in young women during functional MRI: a randomised controlled experiment.
    Siegel P; Wang Z; Murray L; Campos J; Sims V; Leighton E; Peterson BS
    Lancet Psychiatry; 2020 Nov; 7(11):971-981. PubMed ID: 33069319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extinction retention predicts improvement in social anxiety symptoms following exposure therapy.
    Berry AC; Rosenfield D; Smits JA
    Depress Anxiety; 2009; 26(1):22-7. PubMed ID: 18781661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mediating role of changes in harm beliefs and coping efficacy in youth with specific phobias.
    Ollendick TH; Ryan SM; Capriola-Hall NN; Reuterskiöld L; Öst LG
    Behav Res Ther; 2017 Dec; 99():131-137. PubMed ID: 29101841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an expanding-spaced vs massed exposure schedule on fear reduction and return of fear.
    Rowe MK; Craske MG
    Behav Res Ther; 1998; 36(7-8):701-17. PubMed ID: 9682526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.